Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Feb 20 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding two recent approvals from the USFDA. The approvals are for Gabapentin Tablets and Canagliflozin and Metformin Hydrochloride Tablets, both to be manufactured at their facility in Moraiya.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases